Literature DB >> 3458948

Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.

N Sato, T Goto, K Haranaka, N Satomi, H Nariuchi, Y Mano-Hirano, Y Sawasaki.   

Abstract

Exposure to highly purified preparations of murine tumor necrosis factor (TNF) resulted in distinct morphologic changes and proliferation inhibition of cultured endothelial cells from the bovine aorta and capillary and of those from the human umbilical vein. The TNF preparation also inhibited the proliferation of bovine aortic smooth muscle cells but failed to inhibit the proliferation of bovine and human fibroblasts. The cytotoxic activity of the TNF preparation was prominent only in bovine capillary endothelial cells. Upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE), and upon PAGE only, of the TNF preparations, the fractions representing growth inhibitory and cytotoxic activities against bovine capillary endothelial cells exactly corresponded to those containing migrated TNF. Treatments of the TNF preparations with heat and polymyxin B revealed that the effects on endothelial cells were not due to possibly contaminated endotoxin. Moreover, growth inhibitory and cytotoxic actions of rabbit TNF on bovine capillary endothelial cells were completely neutralized by the addition of an anti-rabbit TNF monoclonal antibody. These results suggest that TNF causes morphologic changes in, growth inhibition of, and cytotoxicity against, the vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458948

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  65 in total

1.  Anginex, a designed peptide that inhibits angiogenesis.

Authors:  A W Griffioen; D W van der Schaft; A F Barendsz-Janson; A Cox; H A Struijker Boudier; H F Hillen; K H Mayo
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis.

Authors:  Sabina Sangaletti; Claudio Tripodo; Chiara Ratti; Silvia Piconese; Rossana Porcasi; Rosalba Salcedo; Giorgio Trinchieri; Mario P Colombo; Claudia Chiodoni
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

3.  Evaluation of serum levels of tumour necrosis factor-alpha (TNF-alpha) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment.

Authors:  L A Santana-Blank; M Castes; M E Rojas; F Vargas; D Scott-Algara
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

4.  Tumour necrosis factor, cholestatic jaundice, and chronic liver disease.

Authors:  A Jones; P J Selby; C Viner; S Hobbs; M E Gore; T J McElwain
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

5.  Phenotypic modulation of cultured endothelial cells in collagen matrices induced by tumor necrosis factor alpha.

Authors:  S Nakatani; L Lu; N Okada; K Yoshikawa
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

6.  Platelet-derived growth factor indirectly stimulates angiogenesis in vitro.

Authors:  N Sato; J G Beitz; J Kato; M Yamamoto; J W Clark; P Calabresi; A Raymond; A R Frackelton
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

7.  Human tumor necrosis factor increases the resistance against Listeria infection in mice.

Authors:  K Kato; A Nakane; T Minagawa; N Kasai; K Yamamoto; N Sato; N Tsuruoka
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

8.  Synergic action between tumor necrosis factor and endotoxins or poly(A.U) on cultured bovine endothelial cells.

Authors:  P A van de Wiel; R H Pieters; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice.

Authors:  C M Thumwood; N H Hunt; W B Cowden; I A Clark
Journal:  Br J Exp Pathol       Date:  1989-06

10.  Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.

Authors:  C L Selinsky; K L Boroughs; W A Halsey; M D Howell
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.